Microvillous inclusion disease (MVID) is a genetic disorder characterized by abnormal development of microvilli and loss of normal intestinal function. The disease primarily affects newborns and infants, causing severe problems with absorption of nutrients and leading to severe digestive disorders, including diarrhea and malabsorption. The pathology is based on a mutation of the genes responsible for the structure and function of the microvilli of the intestinal wall, which leads to their improper organization and, as a result, to impaired absorption of nutrients and essential food components. The main clinical manifestations of the disease are severe diarrhea, susceptibility to infections, unstable or poor nutrition, and delayed physical and mental development.
History of the disease and interesting historical facts
The history of microvillous inclusion disease goes back to the 1970s, when the clinical manifestation of this disease was first described. Specialists noticed characteristic changes in the intestinal cells of patients with chronic diarrhea, which later became the basis for further research. In the 1980s, scientists began to identify gene mutations such as MYO5B and ANKRD17 associated with MVD, which opened up new horizons in understanding the pathogenesis of the disease. Research continued, and by the 2000s, the classification of different types of the disease was finally formulated depending on the genes involved.
Epidemiology
The epidemiology of microvillous inclusion disease describes its rarity. According to studies, MVD occurs with a frequency of approximately 1 case per 100,000 newborns. The disease is predominantly observed in children from families with a predisposition to hereditary pathologies. Factors affecting statistics can vary depending on the geographic region, ethnicity, and even environmental conditions. It is important to note that higher rates of disease are observed among men, which confirms the influence of gender predisposition.
Genetic predisposition to this disease
Microvillous inclusion disease is caused by genetic mutations that affect various genes that play a key role in the formation and function of microvilli. The most well-known of these are:
- MYO5B is responsible for the normal transport of cellular components.
- ANKRD17 is involved in cell adhesion and microvilli linking function.
- FAM149A - encodes proteins necessary for the regulation of cellular structure.
Mutations in these genes lead to defects in the formation of microvilli, which in turn causes intestinal dysfunction. Sometimes the disease is inherited in an autosomal recessive manner, which imposes certain additional risks for future generations.
Risk factors for the development of this disease
Although the main cause of the disease is genetic mutations, there are risk factors that contribute to a more severe course of the disease. These include:
- Physical factors: low birth weight, prematurity.
- Chemical factors: exposure to certain toxins in the womb.
- Immunological factors: the presence of diseases that affect the mother's immune response.
These conditions can increase the likelihood of developing symptoms of the disease and complicate its diagnosis and treatment.
Diagnosis of this disease
Diagnosis of microvillous inclusion disease is a multi-step process. The main symptoms include:
- Chronic diarrhea, often with an admixture of fat.
- Malabsorption syndrome: weight loss, growth retardation.
- Frequent intestinal infections.
Laboratory tests, such as stool analysis for fat and intestinal mucosal biopsy followed by morphological examination, are used to confirm the diagnosis. Radiological examinations, including oligosaccharide testing, help assess the degree of absorption. It is also important to conduct a differential diagnosis to exclude other possible intestinal pathologies.
Treatment
Treatment of microvillous inclusion disease requires a comprehensive approach. Includes:
- General treatment: nutritional correction with the inclusion of specialized formulas for children with malabsorption syndrome.
- Pharmacological treatment: use of enzymes to improve digestion and drugs that reduce the inflammatory response.
- Surgical treatment: In rare cases, resection of damaged areas of the intestine may be required.
In addition to the main treatment methods, additional procedures are prescribed aimed at improving the general condition of patients and correcting complications.
List of medications used to treat this disease
Medications that may be used for treatment include:
- Lipases (enzymes for improving fat digestion).
- Antibiotics (for the treatment of infectious complications).
- Cellulose supplements (to improve bowel health).
Each of these remedies is selected individually depending on the patient’s condition and the severity of the disease.
Disease monitoring
Monitoring patients with microvillous inclusion disease requires regular follow-up steps, which include:
- Regular check-ups and tests to check your nutrient absorption levels.
- Assessment of the dynamics of growth and development of the child.
- Monitoring for possible complications such as intestinal infections or vitamin deficiencies.
The prognosis of the disease depends on timely diagnosis and treatment. Complications can lead to serious consequences, so constant monitoring of the patient's condition is important.
Age-related features of the disease
Microvillous inclusion disease has its own characteristics depending on the patient's age. In newborns, symptoms may be more pronounced, which is due to insufficient adaptation of the intestine to the digestion process. In childhood, the disease can lead to delays in growth and development, while in adults with an established diagnosis, the main emphasis is on the prevention of acute conditions and nutritional correction.
Questions and Answers
- What causes microvillous inclusion disease? The main cause is a genetic predisposition, which occurs as a result of mutations in specific genes responsible for the function of microvilli.
- What are the symptoms of this disease? Chronic diarrhea, failure to thrive, poor absorption of nutrients and frequent infections are the main symptoms of MVD.
- How is microvillous inclusion disease diagnosed? Diagnosis is based on clinical examination, stool tests, intestinal biopsy and differential diagnosis to exclude other diseases.
- What are the treatment methods for this disease? Treatment includes dietary modification, pharmacological intervention, and in rare cases, surgery.
- What is the prognosis for people with microvillous inclusion disease? The prognosis depends on the speed of diagnosis and the adequacy of treatment; with constant monitoring of the condition, patients can lead a full life.
